This site is intended for healthcare professionals

2625 pages added, reviewed or updated during the last month (last updated: 15/4/2021)

2625 pages added, reviewed or updated during the last month (last updated: 15/4/2021)


Medical search

hydroxyurea

FREE subscriptions for doctors and students... click here
You have 3 more open access pages.

Hydroxycarbamide (former British Approved Name hydroxyurea) is a ribonucleoside reductase inhibitor that suppresses cell division. Its main use is in the treatment of chronic myeloid leukaemia but it also has a prophylactic role in the management of sickle cell anaemia.

Hydroxycarbamide has replaced the alkylating agents busulphan and chlorambucil as the most commonly used cytotoxic therapy in polycythaemia rubra vera in the UK.

Hydroxycarbamide is not thought to increase the long-term risk of leukaemic transformation, unlike alkylating agents and radio-phosphorous. Nausea and skin reactions are the most common toxic effects.

Last reviewed 01/2018

Links: